In this investigation, five‐year, low‐risk Tyrer‐Cuzick gene expression profile, expected to be negatively correlated with risk, was associated with certain, more aggressive breast cancer subtypes, including basal‐like and HER2‐enriched subtypes. This evidence concerns the gene ERBB2 and breast carcinoma.